Longstanding relationships with the right investigative sites are integral to the success of every clinical trial. With extensive experience working with thousands of investigators around the world in multiple therapeutic specialties involved in drug and device development, Medpace ensures investigators are selected correctly the first time and global study enrollment proceeds quickly and efficiently.
Our comprehensive selection process requires every site’s Primary Investigator and Coordinator undergo detailed interviews with our therapeutically-focused experts to guarantee proficiency with each study protocol and ensure the site has the patient population and capacity to conduct the study.
We know what it takes to make projects successful and that’s why we’ve developed consistent, longstanding, and positive relationships with a global network of investigative sites. Medpace Clinical Research Associates (CRAs) provide the best organizational representation to our sites – and, as a result, investigators welcome a collegiate relationship and prioritize Medpace studies.